QuantRx Biomedical Corporation Announces FDA Filing Of IND For CardioPET, A Novel PET Imaging Agent By FluoroPharma (43.4% Owned By QuantRx Biomedical Corporation)

AMBLER, PA--(MARKET WIRE)--Jun 13, 2006 -- QuantRx® BioMedical Corporation (OTC BB:QTXB.OB - News) announced that FluoroPharma, Inc. (43.4% owned by QuantRx®) has filed its first Investigational New Drug (IND) application for CardioPET molecular imaging agent.